Skip to main content
Yunkang Group Limited logo

Yunkang Group Limited — Investor Relations & Filings

Ticker · 2325 ISIN · KYG9889T1067 HKEX Human health and social work activities
Open in API
Filings indexed 1,527 across all filing types
Latest filing 2022-05-04 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2325

About Yunkang Group Limited

http://www.yunkanghealth.com

Yunkang Group Limited is a leading medical operation service platform specializing in standardized medical diagnostic services. The company provides comprehensive clinical diagnostic capabilities to collaborative hospitals and integrated healthcare systems (hospital alliances). Its core business lines include diagnostic testing services and diagnostic outsourcing services for medical institutions, as well as diagnostic testing for non-medical clients. Yunkang leverages a nationwide service network and operates independent clinical laboratories (ICLs) across key regions. These ICLs often hold dual international accreditations, such as ISO15189 and CAP, ensuring high-quality, full-range clinical diagnostic support.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities (for the month ended 30 April 2022)
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 30 April 2022. It details movements in issued shares, convertibles, and confirms no changes in authorized share capital. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital and share movements for a specific month. It does not contain financial statements, earnings data, or management discussion. It is a regulatory filing related to share capital movements and compliance with listing rules, not a financial report or announcement of voting results. Therefore, it fits best under Regulatory Filings (RNS). The document length is about 5,054 characters, which is substantive but not a full financial report. Hence, classification as RNS is appropriate with high confidence.
2022-05-04 English
PHIP (1st submission)
Audit Report / Information Classification · 95% confidence The document is a 'PHIP' (Post-Hearing Information Proof), which is a standard regulatory filing used by companies in Hong Kong (HKEX) during the IPO process. It contains links to various sections of a prospectus, including business, financial information, and appendices. Since it is a landing page/index for a prospectus filing rather than a specific report like an annual report or earnings release, and it serves as a regulatory disclosure of the document's availability, it falls under the 'Regulatory Filings' category. FY 2021
2022-04-29 English
PHIP (1st submission)
Regulatory Filings Classification · 95% confidence The document is titled 'Post Hearing Information Pack' and is issued by Yunkang Group Limited. It is described as a draft document required by The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission for providing information to the public in Hong Kong. The document explicitly states it is not a prospectus or an offer to sell securities and is incomplete and subject to change. It contains warnings about the legal restrictions and disclaimers about the offering process. The content includes sections such as summary, definitions, risk factors, corporate information, industry overview, regulations, business, directors and senior management, share capital, financial information, and future plans. The document is clearly related to a securities offering and listing process but is not the final prospectus or a financial report. It is a regulatory disclosure document providing information post hearing with the exchange and commission, typically part of the listing process. Given the nature of the document as an informational pack related to a public offering and listing application, and the emphasis on it being a draft and incomplete, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories. It is not a full Annual Report, Interim Report, Earnings Release, or any other specific financial or governance report. It is also not a Report Publication Announcement since it is a substantive document itself, not just an announcement of a report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2022-04-29 English
Notification of Board Meeting
Regulatory Filings Classification · 95% confidence The document is a short announcement from Lenovo Group Limited notifying the market of an upcoming board meeting scheduled for May 26, 2022. The purpose of the meeting includes considering and potentially approving the audited financial results for the fiscal year ended March 31, 2022, and discussing a final dividend. The document does not contain any financial data or detailed report content itself; it merely informs about the meeting date and agenda. The length is only 1452 characters, which is quite short and consistent with an announcement rather than a full report. According to the rules, such a notification of a board meeting is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not fit into more specific categories like Annual Report or Earnings Release. It is not a Board/Management Information (MANG) filing because it does not announce changes in board or management personnel, only a meeting date. Therefore, the appropriate classification is Regulatory Filings (RNS).
2022-04-26 English
Monthly Return of Equity Issuer on Movements in Securities (for the month ended 31 March 2022)
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 31 March 2022. It details movements in issued shares, share options, convertibles, and other share capital related information. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital and share movements for a specific month. It does not contain financial statements, earnings data, or management discussion. It is a regulatory filing related to share capital movements and compliance with listing rules, not a financial report or announcement of voting results. Therefore, it fits best under Regulatory Filings (RNS). The document length is about 5,000 characters, and it is a full submission, not just an announcement of a report.
2022-04-04 English
Application Proof (1st submission)
Audit Report / Information Classification · 95% confidence The document is an 'Application Proof' for Yunkang Group Limited, which is a standard term used in the Hong Kong Stock Exchange (HKEX) for a preliminary prospectus filed during an Initial Public Offering (IPO) process. The structure includes sections typical of a prospectus, such as 'Risk Factors', 'Industry Overview', 'Business', 'Financial Information', and 'Accountant's Report'. Since the provided categories do not include a specific 'IPO Prospectus' code, and it is a regulatory filing related to a capital market event, it falls under the 'Regulatory Filings' (RNS) category as the most appropriate fallback. FY 2021
2022-03-21 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.